WP-2 is run by Alberto Costa and the Cancer World
Team at the European School of Oncology, Milan, Italy. WP-2 makes
available ESO’s communication expertise and capacity to help
the identified target audiences to successfully receive the results
of the EUROCHIP WPs with the final aim of bridging the way of European
cancer information to cancer stakeholders such as cancer patients,
health policy makers and health care professionals.
ESO organized a one-day media training course for
WP-4 and WP-5 experts to learn how to speak with journalists.
|WP-5 media training
|WP-4 media training
Moreover ESO produced media guides for WP-4 activities
and various other dissemination activities.
The EUROCHIP-3 project published the following
scientific articles and chapters:
- Arbyn M, Weiderpass E, Capocaccia R. Effect
of screening on deaths from cervical cancer in Sweden.
BMJ. 2012 Mar 1;344:e804.
- Kivistik A, Lang K, Baili P, Anttila A, Veerus P. Women's
knowledge about cervical cancer risk factors, screening, and
reasons for non-participation in cervical cancer screening
programme in Estonia. BMC Womens Health.11:43.2011.
- Arbyn M, Antoine J, Mägi M, Smailyte G, Stengrevics
A, Suteu O, Valerianova Z, Bray F, Weiderpass E. Trends
in cervical cancer incidence and mortality in the Baltic countries,
Bulgaria and Romania. Int J Cancer. 128(8):1899-907. 2011.
- Arbyn M, Bruni L, de Sanjosé S, Guan P, Ferlay J,
Bray F. Prevalence of human papillomavirus infection and burden
of cervical cancer in Europe in 2008. In: Ayhan A, Reed N,
Gultekin M, Dursun P, editors. ESGO Textbook of Gynaecological
Oncology. European Society of Gynaecologic Oncology, 2011:
- Arbyn M, Castellsagué X, de Sanjosé S, Bruni
L, Saraiya M, Bray F et al. Worldwide
burden of cervical cancer in 2008. Ann Oncol 2011; 22:
- Micheli A, Baili P, Ciampichini R, Verdecchia A. Evaluating
the outcomes of cancer control. In Elwood JM, Sutcliffe AB
(Ed) Cancer control. Oxford university press, New York. (2010)
- Apostol I, Baban A, Nicula F, Suteu O, Coza D, Amati C,
Baili P; EUROCHIP Working Group. Cervical
cancer assessment in Romania under EUROCHIP-2. Tumori96(4):545-52,
- Valerianova Z, Panayotova Y, Amati C, Baili P; EUROCHIP
Working Group. Cervical
cancer screening in Bulgaria--past and present experience.
Tumori 96(4):538-44, 2010;
- Viberga I, Engele L, Baili P; EUROCHIP Working Group. Past,
present and future of the cervical cancer screening in Latvia.
Tumori 96(4):529-37, 2010;
- Veerus P, Arbyn M, Amati C, Baili P; EUROCHIP Working Group.
of implementing a nationwide cervical cancer screening program
on female population coverage by Pap-tests in Estonia.
Tumori 96(4):524-8, 2010:
- Arbyn M, Antoine J, Valerianova Z, Mägi M, Stengrevics
A, Smailyte G, Suteu O, Micheli A. Trends
in cervical cancer incidence and mortality in Bulgaria, Estonia,
Latvia, Lithuania and Romania. Tumori 96(4): 517-23, 2010;
- Anttila A, Arbyn M, Veerus P, Viberga I, Kurtinaitiene R,
Valerianova Z, Apostol I, Baili P, Micheli A. Barriers
in cervical cancer screening programs in new European Union
member states. Tumori 96(4):515-6, 2010;
- Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A: Trends
of cervical cancer mortality in the member states of the European
Union. Eur J Cancer, 45(15): 2640-8, 2009;
- Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, et al: International
collaborations in cancer control and the Third International
Cancer Control Congress. Tumori, 95(5): 579-596, 2009;
Cancer World articles
The EUROCHIP-3 WPs presented own results in the